Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
Arglabin
95
CHF
CHF 95.00
In stock
AG-CN2-0458-M0011 mgCHF 95.00
AG-CN2-0458-M0055 mgCHF 380.00
Product Details | |
---|---|
Synonyms | Arglabine |
Product Type | Chemical |
Properties | |
Formula |
C15H18O3 |
MW | 246.3 |
CAS | 84692-91-1 |
Source/Host Chemicals | Semi-synthetic from parthenolide (AG-CN2-0455), which is isolated from Magnolia grandiflora. |
Purity Chemicals | ≥95% (HPLC) |
Appearance | White to off-white solid. |
Solubility | Soluble in dry DMSO, 100% ethanol or methanol. Insoluble in water. |
Identity | Determined by 1H-NMR. |
InChi Key | UVJYAKBJSGRTHA-CUZKYEQNSA-N |
Smiles | [H][C@@]12CC[C@]3(C)O[C@@]33CC=C(C)[C@]3([H])[C@@]1([H])OC(=O)C2=C |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice | Protect from light. |
Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
- Anticancer compound.
- Farnesyltransferase inhibitor.
- Potent anti-inflammatory agent.
- NF-κB inhibitor.
- Inflammasome inhibitor.
- Antiatherogenic. Prevents the accumulation of lipid containing plaques in arteries.
Product References
- In vitro biological activities of arglabin, a sesquiterpene lactone from the Chinese herb Artemisia myriantha Wall: C. Bottex-Gauthier, et al.; Biotechnol. Ther. 4, 77 (1993)
- Arglabin-DMA, a plant derived sesquiterpene, inhibits farnesyltransferase: T.E. Shaikenov, et al.; Oncol. Rep. 8, 173 (2001)
- Biomimetic semisynthesis of arglabin from parthenolide: J.D. Zhai, et al.; JOC 77, 7103 (2012)
- Synthesis and biological evaluation of antitumor-active arglabin derivatives: R. Csuk, et al.; Arch Pharm. 345, 215 (2012)
- Sesquiterpene lactones and their derivatives inhibit high glucose-induced NF-κB activation and MCP-1 and TGF-β1 expression in rat mesangial cells: Q.Q. Jia, et al.; Molecules 18, 13061 (2013)
- Hemisynthesis of a naturally occurring clinically significant antitumor arglabin from ludartin: S.H. Lone & K.A. Bhat; THL 56, 1908 (2015)
- Anti-Inflammatory and antiatherogenic effects of the NLRP3 Inflammasome inhibitor Arglabin in ApoE2.Ki mice fed a high-fat diet: A. Abderrazak, et al.; Circulation 131, 1061 (2015)